Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $656.26 billion, total revenue of $165.59 billion and a weighted average PE ratio of 37.31.
Market Cap
656.26B
Revenue
165.59B
Profits
17.59B
PE Ratio
37.31
Profit Margin
10.62%
Dividend Yield
0.25%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 182.60B | 2.39% | 2,272,039 | 44.56B |
| 2 | DHR | Danaher Corporation | 134.18B | 3.11% | 4,659,398 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.74B | 0.86% | 822,810 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.21B | 1.99% | 2,469,368 | 7.07B |
| 5 | WAT | Waters Corporation | 29.21B | 1.51% | 1,270,090 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.63B | 2.64% | 1,354,910 | 16.31B |
| 7 | NTRA | Natera, Inc. | 28.34B | 7.04% | 1,418,752 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.54B | 1.06% | 212,991 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.99B | 1.21% | 807,296 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.53B | -0.60% | 1,268,732 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 18.85B | 2.03% | 1,385,880 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 13.63B | 4.32% | 322,912 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 12.12B | 7.16% | 2,999,714 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.80B | 3.34% | 1,255,991 | 2.86B |
| 15 | CRL | Charles River Laboratories International, Inc. | 8.49B | 8.00% | 1,179,959 | 4.02B |
| 16 | ICLR | ICON Public Limited Company | 8.45B | 5.29% | 1,188,699 | 8.10B |
| 17 | QGEN | Qiagen N.V. | 8.25B | 1.83% | 1,379,765 | 2.09B |
| 18 | RDNT | RadNet, Inc. | 4.34B | 0.27% | 858,392 | 2.04B |
| 19 | SHC | Sotera Health Company | 4.08B | 8.23% | 5,748,294 | 1.16B |
| 20 | BLLN | BillionToOne, Inc. | 3.63B | 12.59% | 299,914 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 2.91B | 9.85% | 1,413,055 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.56B | 5.81% | 1,054,653 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 2.12B | 10.19% | 1,272,172 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.88B | 7.73% | 598,458 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 963.21M | 3.06% | 1,261,132 | 727.33M |
| 26 | CDNA | CareDx, Inc. | 889.12M | 5.66% | 862,813 | 379.81M |
| 27 | OPK | OPKO Health, Inc. | 865.34M | 3.64% | 2,573,511 | 606.88M |
| 28 | CSTL | Castle Biosciences, Inc. | 729.90M | 4.25% | 431,471 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 666.50M | 2.08% | 1,976,845 | 69.65M |
| 30 | FLGT | Fulgent Genetics, Inc. | 496.57M | 1.73% | 499,576 | 322.67M |
| 31 | MYGN | Myriad Genetics, Inc. | 420.79M | 3.21% | 1,225,394 | 824.50M |
| 32 | PRE | Prenetics Global Limited | 325.13M | -3.16% | 122,972 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 173.67M | 0.81% | 26,305 | 77.14M |
| 34 | BDSX | Biodesix, Inc. | 142.95M | 5.15% | 31,412 | 88.50M |
| 35 | FONR | FONAR Corporation | 121.67M | -0.11% | 9,094 | 106.03M |
| 36 | MDXH | MDxHealth SA | 118.14M | - | 178,268 | 107.88M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 105.51M | 28.63% | 1,205,637 | 4.06M |
| 38 | XGN | Exagen Inc. | 72.16M | 13.21% | 186,161 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 43.80M | 4.60% | 11,863 | 24.05M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 17.21M | 8.19% | 1,062,636 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 11.73M | 3.21% | 25,788 | - |
| 42 | NOTV | Inotiv, Inc. | 9.37M | 7.03% | 262,249 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 6.63M | 3.60% | 127,832 | 29.52M |
| 44 | ADVB | Advanced Biomed Inc. | 6.22M | 1.33% | 17,333 | - |
| 45 | QUCY | Mainz Biomed N.V. | 5.93M | 13.81% | 79,944 | 659.94K |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.42M | -0.64% | 15,328 | - |
| 47 | ISPC | iSpecimen Inc. | 1.53M | 9.03% | 1,194,062 | 3.35M |